Tag Archive | "financial"

Tags: , , , , , , , , , , , , , , , , , , , ,

Game Plan Holdings Inc – GPLH


Mission

Game Plan is a technology driven nutrition supplement company that empowers fitness professionals and thought leaders to seamlessly refer nutrition to their clients, athletes, and followers.

Vision

Game Plan will simplify the world of nutritional supplements.

History

Founded in 2009, Game Plan’s goal was to create the highest quality, natural, and cleanest supplements available.

The product quality was so heralded that they found their way into the locker rooms of the NBA, NFL, NHL, MLB, and PGA.

After seeing the state of the nutrition industry, Game Plan innovated through technology and partnerships to provide clientele with a platform centered around user experience, e-commerce, education, customer service, and ease of use.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

DC Brands International Inc – HRDN


Company History

  • Started in 2004 as an Energy Drink Company
  • Dickens Energy Cider
  • Turn Left Energy Drink
  • In 2007 entered the Nutritional Beverage Space – Hard Nutrition
  • Functional Water System: Nine Functions
  • Weight Loss
  • 5 Hours Mental Acuity
  • Full Body Cleanse
  • Hangover Relief
  • Pre & Post Workout
  • 10 Hours All Natural Energy
  • Daily Vitamins
  • In 88 King Sooper’s (Kroger Brand) Grocery Stores along Front Range of Colorado
  • Lost Funding Jan 2013 began restructuring
  • Purchased 15% of Village Tea Company – New York Based Premium loose leaf tea.
  • April 2014 – Announced entry into Colorado Marijuana Industry
  • June 2014 – Signed contract with 1st Client

Colorado Marijuana Industry

  • 2000 Medical Marijuana approved
  • JAN 2014 Recreational Marijuana Sales Began
  • Approximately 500 licenses issued originally
  • In 2014 approximately 225 licenses canceled due to regulatory issues
  • Company’s opinion is regulators are trying to move out the small operators/stoners and get the larger operators/business people involved

Dc Brands Green Investments, Llc Value Proposition

  • Green will offer a bundle of services to Colorado Marijuana Growers and Sellers
  • Accounting
  • Payroll
  • Cash Flow Management
  • Tax Payments
  • Security
  • Laboratory Testing
  • AND Capital for Expansion or Acquisitions
  • In Exchange GREEN will receive a variable rate contract loosely based upon an agreed upon % of sales
  • $1 million invested properly should return approx. $500k in yr 1; $1 million yr 2, $2 million yr 3

Dc Capital Structure

  • 3.8 Billion Shares currently outstanding
  • 5 Billion Common shares authorized
  • 14-C Definitive filed June 6, 2014 increasing authorized to 30 Billion effective June 29, 2014
  • Series A Preferred Stock provides 51.25% voting control – owned by Bob Armstrong CEO
  • Series B –G Preferred Stock convertible into approx. 30% of the company
  • $1 million Senior Secured Debt secured by all assets of DC held by Richard Pearce – former CEO
  • $5 million of unsecured debt (approx.) held by 40 lenders

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , ,

Chelsea Oil and Gas Ltd. – COGLF


Chelsea Oil & Gas is an Australian focused exploration, development and production company. We have a significant portfolio of assets onshore Australia comprised of 5.2 million net acres across four basins:

Each basin offers stacked pay, and the South Georgina, Simpson and Surat Bowen Basins offer billion barrel unconventional resource potential. With up to $545 million of investment on offsetting lands in the next three years by Supermajors, and a low cost program targeting more than 1.0 billion barrels of unrisked prospective resources, Chelsea is well positioned to create significant near-term value for its shareholders.

Corporate Highlights

1) Large, Operated, High Working Interest Resource Base
  • Average 84% operated working interest in 6.2 million acres (5.2 million net) onshore Australia
  • High impact potential in Georgina and Simpson Basins with 3.5 billion barrels recoverable resources
  • Control of the preparation of budgets and schedules facilitates the delivery of value creation strategy
2) Near-Term Path to Value Realization
  • Opportunity set across portfolio defined through seismic, drilling on offsetting acreage and analogues
  • Near-term oil production and existing overriding royalty cashflow offsets G&A

3) Low-Cost, High-Impact Assets Near Existing Infrastructure

  • Offsetting exploration currently underway by Statoil, Total and Santos committing up to $545 million
  • Gas infrastructure less than 150 km from unconventional permit; well established paved roadways and rail network nearby all permits
  • Limited near-term capex required to maintain asset base means the large investment necessary to evaluate the basin’s unconventional resource will be made by off-setting super-majors.

4) Catalyst Rich Exploration and Development Programme

  • Carried for up to 6 exploration wells and 120 km2 of 3D seismic in 2013 / 14 (Cooper Basin)
  • 2 production wells in 2014 targeting 300 bopd 51°oil from existing discoveries (Surat Basin)
  • Additional exploration and development targets to be matured through work programme

5) Favourable Political, Fiscal and Operating Environment

  • Australia has leading Western fiscal regime: 10% state royalty, 30% corporate tax
  • Queensland most active onshore exploration and production state, well serviced by oilfield industry
  • Local demand for oil and gas, LNG export potential for significant discoveries
  • Stable political outlook with investment grade debt rating of Aaa by Moody’s

6) Experienced Board and Management

  • 125+ years of industry experience among directors and senior management
  • Direct experience in horizontal multi-stage frac and unconventional drilling
  • Direct experience with enhanced and secondary recovery techniques

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Readen Holding Corp – RHCO


Readen Holding Corp, a Venture Capital organisation,investor and shareholder of companies operating in hree separate industries. Readen Holding Corp. has access to an extensive, influential and loyal network of business relations and investors.

Readen Group’s mission statement is to be a valuable partner for customers in terms of technical flexibility, quality and competitive pricing through the complete value chain (SIM cards, mobile phones and applications).

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Medient Studios, Inc. (OTCQB: MDNT)


Medient Studios, Inc. (OTCQB: MDNT) is an entertainment content creation company with a strong presence in North America, Europe and India. Medient’s management team has approximately 150 years of experience in the motion picture industry and is responsible for producing and/or financing over 250 movies. Medient is realigning the content creation process to enable efficiencies of scale and eliminate process waste by building a fully integrated movie and game production facility and campus on a 1550 acre property in Effingham County, Georgia. Once operational this production facility will be the largest of its kind in the United States.

The Company has produced a broad spectrum of films across various genres. These include such films as “Bombay Boys”, a genre-defining Indie film that carried Indian cinema beyond the “song and dance” routine of Bollywood, and the award-winning Malayalam film “Aakshagopuram”, which was the first Indian film to be entirely produced outside of that country. The film, which bought together talent from India and the UK, set a new benchmark in East – West collaboration. “Storage 24″, a British horror film starring BAFTA award winner Noel Clarke was produced by Medient and released in 2012 by Universal Pictures.

Medient’s latest film, “Yellow”, is directed by Nick Cassavetes (The Notebook) and premiered to rave reviews and audience acclaim at the 2012 Toronto International Film Festival (“TIFF”). Critic reviews from TIFF included “surreal imagination”…”bizarre parallel realities”…”wildly inventive”…and “a cinematic trip of mind-bending proportions”.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , ,

Time Warner names Averill as new financial chief


Time Warner Inc. TWX +0.63% named Time Inc. financial chief Howard Averill as its new CFO, starting next year.

Mr. Averill will succeed current CFO John Martin when Martin assumes his new role as chief executive of Turner Broadcasting System Inc.

Prior to joining Time Inc. in 2007, Mr. Averill was executive vice president and CFO at NBC Universal Television. Before that, he was an executive at ITT/Sheraton Corp. and also held positions with Pepsi-Cola Co. and Arthur Andersen & Co.

The announcement comes after last week Time Warner named Mr. Martin as Turner’s new CEO, succeeding Phil Kent.

The changes comes as Time Warner is going into a period of transition. In March, it opted to get out of the magazine business by spinning off its entire Time Inc. magazine group, giving up on talks with Meredith Corp. (MDP).

In January, Time Warner named Kevin Tsujihara as the new chief executive of Warner Bros. Entertainment, replacing Barry Meyer, who will remain as the segment’s chairman through 2013.

Shares of Time Warner were up 31 cents to $62.08 in recent trading. The stock has risen 60% in the past 12 months.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

SOURCE: http://www.marketwatch.com/story/time-warner-names-averill-as-new-financial-chief-2013-07-22

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , ,

Experience Art and Design, Inc – EXAD


The Mission.

Enable anyone, anywhere, at any time, to discover and more fully appreciate and experience hundreds of millions of individual works of art and design, whether created millenniums, centuries, days or minutes ago.

The EXPE™ Platform.

They are at work creating a cloud-based software platform that the world of art and design can use to deliver immersive experiences connected to works of art and design. The experiences are delivered, and often produced by, artists and designers using smart phones and other digital image capture devices and software applications.

The platform will be optimized for 2D and 3D photography and video and images, text and audio produced or captured in many file formats. The objective is to enable people to see, hear and sense art and design in new immersive ways.

Showcase the platform.

They first objective is to showcase the EXPE Platform in ways that will inspire hundreds of thousands of other artists and designers to take advantage of the Platform. They will start by featuring sculpture produced by the Chiurazzi Foundry. Experience Art + Design now owns Chiurazzi Internazionale S.r.l., the Naples, Italy, foundry founded in 1870. The foundry produces bronze statues cast from moulds taken directly from the artist’s original sculptures. Visit www.Chiurazzi.com

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , ,

Loews, CNA Financial swing to losses


Loews Corp. L -1.16% swung to a fourth-quarter loss as its CNA Financial Corp. CNA -1.51% insurance unit was hit by losses related to Hurricane Sandy, and because of a large impairment charge at HighMount Exploration & Production LLC.

Led by New York’s Tisch family, Loews has recently seen its bottom line pressured by large impairment charges related to its HighMount unit, as the company has been forced to write down the carrying value of its natural-gas and oil properties to reflect declines in natural-gas and NGL prices. Loews said it took impairment charges of $97 million at HighMount.

The conglomerate owns 90% of CNA Financial, which typically accounts for nearly two-thirds of Loews’s revenue.

For the fourth quarter, Loews reported a loss of $32 million, or eight cents a share, compared with a year-earlier profit of $271 million, or 68 cents a share.

Revenue rose 4.5% to $3.71 billion. Revenue from insurance premiums, its largest top-line contributor, rose 7.4% to $1.78 billion.

CNA Financial recorded a loss of $9 million, or three cents a share, versus a profit of $190 million, or 70 cents a share, a year ago. Analysts polled by Thomson Reuters had most recently forecast earnings of four cents.

CNA’s property and casualty operations recorded net operating income of $60 million, compared with $345 million in the prior-year quarter. The company said the decline was primarily due to losses from superstorm Sandy. The storm’s impact, including reinstatement premiums, was $190 million after taxes, compared with catastrophe losses of $11 million after taxes in the prior-year quarter.

Loews’s other big holdings include Diamond Offshore Drilling Inc. (DO) — which earlier this month said its fourth-quarter earnings fell 17% as lower day rates damped improved utilization of ultradeep-water and midwater floaters–and also Boardwalk Pipeline Partners LP (BWP), which said Monday its profit rose 26% as operating revenue climbed.

Loews shares closed Friday at $43.85, while CNA shares closed at $31.80. Both companies’ stocks were inactive in recent premarket trading.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

SOURCE: http://www.marketwatch.com/story/loews-cna-financial-swing-to-losses-2013-02-11

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , ,

BMC Software profit fell 11% on higher costs


BMC Software Inc. BMC -0.04% fiscal third-quarter earnings fell 11% on higher operating expenses, stock-based compensation charges and other items.

Shares were down 7.3% at $41.25 in recent after-hours trading as adjusted earnings and revenue missed expectations and the company reduced its guidance for the fiscal year. Through the close, the stock is up 12% this year.

The business-software company now expects per-share earnings of $3.35 to $3.45 on revenue growth in the low-single digits on a percentage basis, compared with its prior estimate for a per-share profit of $3.49 to $3.59 and revenue growth in the mid-single digits.

BMC has generally posted improved core profit and revenue by leveraging increased demand for cloud computing, which allows users to run programs and store information remotely, eliminating the cost of operating the equipment themselves.

The company, which has faced challenges from higher costs and soft demand, has been working to strengthen its product pipeline and has been recovering from workforce attrition issues that hurt revenue last year.

“Our overall win rate remains high, but we need to be more consistent and disciplined in how we approach and secure large, transformational deals,” said Chief Executive Bob Beauchamp. “We are scrutinizing the entire company to improve our operational discipline. This review is currently under way, and it should position us well as we enter” the new fiscal year.

For the quarter ended Dec. 31, BMC Software reported a profit of $106.3 million, or 70 cents a share, down from $119.9 million, or 71 cents a share, a year earlier. Excluding share-based compensation and other items, adjusted earnings were up at 99 from 93 cents. Revenue increased 5.8% to $580.2 million.

Analysts polled by Thomson Reuters most recently projected earnings of $1.01 a share on revenue of $587 million.

Selling and marketing expenses increased 14% and overhead costs rose 12%. Research and development costs were up 8.8%.

Maintenance revenue–the biggest contributor to the top line–improved 6% to $232.3 million. Licensing revenue rose 3.2% to $232.3 million, while services revenue climbed 16% to $59.2 million.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

SOURCE: http://www.marketwatch.com/story/bmc-software-profit-fell-11-on-higher-costs-2013-01-28

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Biogen inks drug-development deal with Isis


Biogen Idec (BIIB) inked a deal with Isis Pharmaceuticals Inc. ISIS +4.84% to discover and develop antisense drugs against three undisclosed targets to treat neurological or neuromuscular disorders that could see Isis receive over $230 million.

The deal is the third collaboration between the drug companies.

Shares of Isis rose 5.4% to $9.47 in recent premarket trading, while those of Biogen were inactive. Isis shares have risen 26% in the past year, while Biogen’s have climbed 34%.

“Our latest collaboration with Isis to discover and develop novel targets for the treatment of neurological disorders is a perfect fit within our early-stage research strategy,” said Richard Brudnick, vice president and co-head of business development at Biogen. “By combining Isis’ knowledge with Biogen Idec’s expertise as a leader in neurology, we believe this latest discovery collaboration holds great potential for finding novel approaches to treating neurologic diseases.”

Under the terms of the latest agreement, Isis will receive an upfront payment of $30 million and is responsible for the discovery of a lead antisense drug for each of the three undisclosed targets

Biogen and Isis are also developing antisense drugs to treat spinal muscular atrophy and myotonic dystrophy type 1 under previously established collaborations.

Isis is also eligible to receive substantial development milestone payments prior to the exercise by Biogen of its option to license each program. Biogen has the option to license a drug from each of the three programs through the completion of Phase 2 trials. If Biogen exercises its option, it will assume global development, regulatory and commercialization responsibilities.

Isis will receive double-digit royalties on sales of drugs, and could receive up to another $200 million in a license fee and regulatory milestone payments per program. In addition Isis will be responsible for development of the drugs through the completion of the initial Phase 2 clinical trial, with Biogen providing advice and assistance.

In June, Biogen and Isis said they had entered into an agreement to develop and commercialize an antisense drug to treat Steinert disease, a deal that could see Isis receive more than $271 million. And prior to that, in January, Isis entered into a collaboration agreement with Biogen with a potential value of $299 million to develop and commercialize the drug developer’s investigational treatment for spinal muscular atrophy.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

SOURCE: http://www.marketwatch.com/story/biogen-inks-drug-development-deal-with-isis-2012-12-10-14485552

Posted in Featured, Stock NewsComments Off

Advertise Here